FDA Removes 12 Peptides from 503A Category 2 Newtropin Not all medical oversight is the same and wording matters., Terms like medical oversight and compounded are often used loosely, but true medical care involves licensed providers, proper Last week @fda sends out clarification on who can and cannot compound #glp1 like #tirzeaptide and #semaglutide and this week ProRx 503b shuts down GLP 1 compounding while @martymakary is photographed holding bootleg # Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law